000276804 001__ 276804
000276804 005__ 20250323000851.0
000276804 0247_ $$2doi$$a10.1089/neu.2024.0233
000276804 0247_ $$2pmid$$apmid:39585767
000276804 0247_ $$2ISSN$$a0897-7151
000276804 0247_ $$2ISSN$$a1557-9042
000276804 0247_ $$2altmetric$$aaltmetric:171131233
000276804 037__ $$aDZNE-2025-00329
000276804 041__ $$aEnglish
000276804 082__ $$a610
000276804 1001_ $$00000-0002-2653-5818$$aHubertus, Vanessa$$b0
000276804 245__ $$aIdentification of a Therapeutic Window for Neurovascular Unit Repair after Experimental Spinal Cord Injury.
000276804 260__ $$aLarchmont, NY$$bLiebert$$c2025
000276804 3367_ $$2DRIVER$$aarticle
000276804 3367_ $$2DataCite$$aOutput Types/Journal article
000276804 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1742207080_23586
000276804 3367_ $$2BibTeX$$aARTICLE
000276804 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000276804 3367_ $$00$$2EndNote$$aJournal Article
000276804 520__ $$aTraumatic spinal cord injury (SCI) is a devastating condition for which effective neuroregenerative and neuroreparative strategies are lacking. The post-traumatic disruption of the blood-spinal cord barrier (BSCB) as part of the neurovascular unit (NVU) is one major factor in the complex pathophysiology of SCI, which is associated with edema, inflammation, and cell death in the penumbra regions of the spinal cord adjacent to the lesion epicenter. Thus, the preservation of an intact NVU and vascular integrity to facilitate the regenerative capacity following SCI is a desirable therapeutic target. This study aims to identify a therapeutic window of opportunity for NVU repair after SCI by characterizing the timeframe of its post-traumatic disintegration and reintegration with implications for functional spinal cord recovery. Following thoracic clip-compression SCI or sham injury, adult C57BL/6J mice were followed up from one to 28 days. At one, three, seven, 14, and 28 days after SCI/sham, seven-Tesla magnetic resonance imaging (MRI), neurobehavioral analysis (Basso mouse scale, Tally subscore, CatWalk® gait analysis), and following sacrifice immunohistochemistry were performed, assessing vessel permeability via Evans blue (EVB) extravasation, (functional) vessel density, and NVU integrity. Thy1-yellow fluorescent protein+ mice were additionally implanted with a customized spinal window chamber and received longitudinal in vivo two-photon excitation imaging (2PM) with the injection of rhodamine-B-isothiocyanate-dextran for the combined imaging of axons and vasculature up to 14 days after SCI/sham injury. Post-traumatic edema formation as assessed by MRI volumetry peaked at one to three days after injury, while EVB permeability quantification revealed a thoroughly injured BSCB up to 14 days after SCI. Partial regeneration of functional vasculature via endogenous revascularization was detected after one to four weeks, however, with only 50-54% of existing vessels regaining functional perfusion. Longitudinal in vivo 2PM visualized the progressive degeneration of initially preserved spinal cord axons in the peri-traumatic zone after SCI while displaying a rarefication of functionally perfused vessels up to two weeks after injury. Neurobehavioral recovery started after one week but remained impaired over the whole observation period of four weeks after SCI. With this study, a therapeutic window to address the impaired NVU starting from the first days to two weeks after SCI is identified. A number of lines of evidence including in vivo 2PM, assessment of NVU integrity, and neurobehavioral assessments point to the critical nature of targeting the NVU to enhance axonal preservation and regeneration after SCI. Continuous multifactorial therapy applications targeting the integrity of the NVU over the identified therapeutic window of opportunity appears promising to ameliorate functional vessel perseverance and the spinal cord's regenerative capacity.
000276804 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000276804 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000276804 650_7 $$2Other$$aneurovascular unit
000276804 650_7 $$2Other$$aspinal cord injury
000276804 650_7 $$2Other$$aspinal cord regeneration
000276804 650_7 $$2Other$$avascular injury
000276804 650_7 $$2Other$$avascular regeneration
000276804 650_2 $$2MeSH$$aSpinal Cord Injuries: physiopathology
000276804 650_2 $$2MeSH$$aSpinal Cord Injuries: diagnostic imaging
000276804 650_2 $$2MeSH$$aAnimals
000276804 650_2 $$2MeSH$$aMice
000276804 650_2 $$2MeSH$$aMice, Inbred C57BL
000276804 650_2 $$2MeSH$$aRecovery of Function: physiology
000276804 650_2 $$2MeSH$$aFemale
000276804 650_2 $$2MeSH$$aDisease Models, Animal
000276804 650_2 $$2MeSH$$aMagnetic Resonance Imaging
000276804 650_2 $$2MeSH$$aNerve Regeneration: physiology
000276804 650_2 $$2MeSH$$aTime Factors
000276804 7001_ $$aMeyer, Lea$$b1
000276804 7001_ $$aWaldmann, Lilly$$b2
000276804 7001_ $$aRoolfs, Laurens$$b3
000276804 7001_ $$aTaheri, Nima$$b4
000276804 7001_ $$aKersting, Katharina$$b5
000276804 7001_ $$avon Bronewski, Emily$$b6
000276804 7001_ $$aNieminen-Kelhä, Melina$$b7
000276804 7001_ $$aKremenetskaia, Irina$$b8
000276804 7001_ $$aUhl, Christian$$b9
000276804 7001_ $$aFiedler, Kim C$$b10
000276804 7001_ $$aOde, Jan-Erik$$b11
000276804 7001_ $$aRex, Andre$$b12
000276804 7001_ $$0P:(DE-2719)2810931$$aPrüß, Harald$$b13$$udzne
000276804 7001_ $$00000-0003-3152-1557$$aRakhymzhan, Asylkhan$$b14
000276804 7001_ $$aHauser, Anja E$$b15
000276804 7001_ $$aNiesner, Raluca$$b16
000276804 7001_ $$0P:(DE-2719)2812386$$aHeppner, Frank L$$b17$$udzne
000276804 7001_ $$00000-0002-5722-6364$$aFehlings, Michael G$$b18
000276804 7001_ $$00000-0003-4350-392X$$aVajkoczy, Peter$$b19
000276804 773__ $$0PERI:(DE-600)2030888-7$$a10.1089/neu.2024.0233$$gVol. 42, no. 3-4, p. 212 - 228$$n3-4$$p212 - 228$$tJournal of neurotrauma$$v42$$x0897-7151$$y2025
000276804 909CO $$ooai:pub.dzne.de:276804$$pVDB
000276804 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810931$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000276804 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812386$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b17$$kDZNE
000276804 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000276804 9141_ $$y2025
000276804 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-18$$wger
000276804 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROTRAUM : 2022$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000276804 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000276804 9201_ $$0I:(DE-2719)1810003$$kAG Prüß$$lAutoimmune Encephalopathies$$x0
000276804 9201_ $$0I:(DE-2719)1810007$$kAG Heppner$$lNeuroimmunology$$x1
000276804 980__ $$ajournal
000276804 980__ $$aVDB
000276804 980__ $$aI:(DE-2719)1810003
000276804 980__ $$aI:(DE-2719)1810007
000276804 980__ $$aUNRESTRICTED